Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12932
Title: Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
Austin Authors: Horowitz, J D;Henry, C A;Syrjanen, M L;Louis, William J ;Fish, R D;Smith, T W;Antman, E M
Affiliation: Department of Cardiology, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 1-Apr-1988
Publication information: Circulation; 77(4): 787-94
Abstract: The vasodilator effects of nitroglycerin (NTG) are mediated via activation of guanylate cyclase; this process is believed to require the availability of free sulfhydryl groups. Previous studies in man have shown that the sulfhydryl donor N-acetylcysteine (NAC) potentiates the systemic and coronary vasodilator effects of NTG. Furthermore, interaction of NTG and NAC may lead to the formation of S-nitroso-NAC, which strongly inhibits platelet aggregation. The effects of intravenous NTG combined with intravenous NAC (5 g 6 hourly) were compared with those of intravenous NTG alone in a double-blind trial in 46 patients with severe unstable angina pectoris unresponsive to conventional treatment, which included calcium antagonists and cutaneous nitrates in all but one patient. Treatment with NTG/NAC (24 patients) and that with NTG alone (22 patients) was associated with a similar frequency of episodes of chest pain and of increments in NTG infusion rate for pain control (10 vs 17; p = NS). The NTG/NAC group had a significantly lower incidence of acute myocardial infarction than the NTG/placebo group (three vs 10 patients; p = .013). Symptomatic hypotension occurred frequently in the NTG/NAC group (seven vs 0 patients; p = .006). Lactate-pyruvate ratios and venous NTG concentrations were not significantly affected by NAC. Subsequently, another 20 consecutive patients were treated with intravenous NTG and continuously infused NAC (10 g/day). Seven remained pain free during the first 24 hr of NTG infusion; 11 required increments in NTG infusion rate for pain control. Acute myocardial infarction occurred in one patient, while none developed symptomatic hypotension.(ABSTRACT TRUNCATED AT 250 WORDS)
Gov't Doc #: 3127076
URI: https://ahro.austin.org.au/austinjspui/handle/1/12932
Journal: Circulation
URL: https://pubmed.ncbi.nlm.nih.gov/3127076
Type: Journal Article
Subjects: Acetylcysteine.administration & dosage.adverse effects.therapeutic use
Angina Pectoris.drug therapy
Angina, Unstable.drug therapy
Clinical Trials as Topic
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Hypotension.chemically induced
Male
Myocardial Infarction.prevention & control
Nitroglycerin.administration & dosage.therapeutic use
Random Allocation
Risk Factors
Appears in Collections:Journal articles

Show full item record

Page view(s)

10
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.